Marzena Wątek

1.3k total citations
27 papers, 762 citations indexed

About

Marzena Wątek is a scholar working on Molecular Biology, Microbiology and Hematology. According to data from OpenAlex, Marzena Wątek has authored 27 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Molecular Biology, 7 papers in Microbiology and 6 papers in Hematology. Recurrent topics in Marzena Wątek's work include Antimicrobial Peptides and Activities (7 papers), Sphingolipid Metabolism and Signaling (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Marzena Wątek is often cited by papers focused on Antimicrobial Peptides and Activities (7 papers), Sphingolipid Metabolism and Signaling (6 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Marzena Wątek collaborates with scholars based in Poland, United States and Russia. Marzena Wątek's co-authors include Robert Bucki, Katarzyna Niemirowicz, Ewelina Piktel, Tomasz Wollny, Bonita Durnaś, Urszula Wnorowska, Paul B. Savage, Stanisław Góźdż, Piotr Deptuła and Agnieszka Z. Wilczewska and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and PLoS ONE.

In The Last Decade

Marzena Wątek

27 papers receiving 749 citations

Peers

Countries citing papers authored by Marzena Wątek

Since Specialization

Citations

This map shows the geographic impact of Marzena Wątek's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marzena Wątek with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marzena Wątek more than expected).

Fields of papers citing papers by Marzena Wątek

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Marzena Wątek. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marzena Wątek. The network helps show where Marzena Wątek may publish in the future.

Co-authorship network of co-authors of Marzena Wątek

This figure shows the co-authorship network connecting the top 25 collaborators of Marzena Wątek. A scholar is included among the top collaborators of Marzena Wątek based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Marzena Wątek. Marzena Wątek is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Hypogelsolinemia and Decrease in Blood Plasma Sphingosine-1-Phosphate in Patients Diagnosed with Severe Acute Pancreatitis 2021 ·Digestive Diseases and Sciences ·Tomasz Wollny, Marzena Wątek, Urszula Wnorowska, Ewelina Piktel, Stanisław Góźdż, Krzysztof Kurek, Przemysław Wolak, Grzegorz Król, Małgorzata Żendzian‐Piotrowska, Robert Bucki	5
2	Hematological malignancies in Polish population: what are the predictors of outcome in patients admitted to Intensive Care Unit? 2020 ·Supportive Care in Cancer ·Elżbieta Kalicińska, (unknown), (unknown), (unknown), Marzena Wątek, (unknown), Justyna Rybka, Jarosław Czyż, Ewa Lech‐Marańda, Jan Maciej Zaucha, Tomasz Wróbel	6
3	Defective Sphingolipids Metabolism and Tumor Associated Macrophages as the Possible Links Between Gaucher Disease and Blood Cancer Development 2019 ·International Journal of Molecular Sciences ·Marzena Wątek, Ewelina Piktel, Tomasz Wollny, Bonita Durnaś, Krzysztof Fiedoruk, Ewa Lech‐Marańda, Robert Bucki	25
4	Decreased Activity of Blood Acid Sphingomyelinase in the Course of Multiple Myeloma 2019 ·International Journal of Molecular Sciences ·Marzena Wątek, Ewelina Piktel, Joanna Barankiewicz, (unknown), (unknown), (unknown), Łukasz Suprewicz, Przemysław Wolak, Bonita Durnaś, Robert Bucki, Ewa Lech‐Marańda	6
5	Targeting polyelectrolyte networks in purulent body fluids to modulate bactericidal properties of some antibiotics 2018 ·Infection and Drug Resistance ·Robert Bucki, Bonita Durnaś, Marzena Wątek, Ewelina Piktel, Katrina Cruz, Przemysław Wolak, Paul B. Savage, Paul A. Janmey	10
6	Unexpected profile of sphingolipid contents in blood and bone marrow plasma collected from patients diagnosed with acute myeloid leukemia 2017 ·Lipids in Health and Disease ·Marzena Wątek, Bonita Durnaś, Tomasz Wollny, Marcin Pasiarski, Stanisław Góźdż, Michał Marzec, (unknown), Przemysław Wolak, Małgorzata Żendzian‐Piotrowska, Robert Bucki	25
7	Anaerobic bacteria growth in the presence of cathelicidin LL-37 and selected ceragenins delivered as magnetic nanoparticles cargo 2017 ·BMC Microbiology ·Bonita Durnaś, Ewelina Piktel, Marzena Wątek, Tomasz Wollny, Stanisław Góźdż, Jolanta Smok-Kalwat, Katarzyna Niemirowicz, Paul B. Savage, Robert Bucki	32
8	Pharmacokinetics and Anticancer Activity of Folic Acid-Functionalized Magnetic Nanoparticles 2017 ·Journal of Biomedical Nanotechnology ·Katarzyna Niemirowicz, Halina Car, Anna Sadowska, Marzena Wątek, (unknown), Marzanna Cechowska‐Pasko, Agnieszka Z. Wilczewska, Joanna Mystkowska, Irena Kasacka, Anna Torres, Robert Bucki	11
9	Recent insights in nanotechnology-based drugs and formulations designed for effective anti-cancer therapy 2016 ·Journal of Nanobiotechnology ·Ewelina Piktel, Katarzyna Niemirowicz, Marzena Wątek, Tomasz Wollny, Piotr Deptuła, Robert Bucki	126
10	Candidacidal Activity of Selected Ceragenins and Human Cathelicidin LL-37 in Experimental Settings Mimicking Infection Sites 2016 ·PLoS ONE ·Bonita Durnaś, Urszula Wnorowska, Katarzyna Pogoda, Piotr Deptuła, Marzena Wątek, Ewelina Piktel, Stanisław Głuszek, Xiaobo Gu, Paul B. Savage, Katarzyna Niemirowicz, Robert Bucki	71
11	Utility of blood procalcitonin concentration in the management of cancer patients with infections 2016 ·OncoTargets and Therapy ·Katarzyna Niemirowicz, Bonita Durnaś, Marzena Wątek, Tomasz Wollny, Robert Bucki, Stanisław Góźdż, Michał Marzec	29
12	Core–shell magnetic nanoparticles display synergistic antibacterial effects against <em>Pseudomonas aeruginosa</em> and <em>Staphylococcus aureus</em> when combined with cathelicidin LL-37 or selected ceragenins 2016 ·International Journal of Nanomedicine ·Katarzyna Niemirowicz, Ewelina Piktel, Agnieszka Z. Wilczewska, Karolina H. Markiewicz, Bonita Durnaś, Marzena Wątek, (unknown), Marta Wróblewska, Wiesława Niklińska, Paul B. Savage, Robert Bucki	60
13	Magnetic nanoparticles as a drug delivery system that enhance fungicidal activity of polyene antibiotics 2016 ·Nanomedicine Nanotechnology Biology and Medicine ·Katarzyna Niemirowicz, Bonita Durnaś, Grażyna Tokajuk, (unknown), Agnieszka Z. Wilczewska, Iwona Misztalewska‐Turkowicz, Joanna Mystkowska, (unknown), (unknown), Marzena Wątek, Bożena Kiziewicz, Stanisław Góźdż, Stanisław Głuszek, Robert Bucki	56
14	The Role of Cathelicidin LL-37 in Cancer Development 2015 ·Archivum Immunologiae et Therapiae Experimentalis ·Ewelina Piktel, Katarzyna Niemirowicz, Urszula Wnorowska, Marzena Wątek, Tomasz Wollny, (unknown), Stanisław Góźdż, Ilya Levental, Robert Bucki	86
15	Novel Cryptic Rearrangements in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Involving the MLL Gene 2015 ·Journal of Histochemistry & Cytochemistry ·(unknown), Beata Grygalewicz, Barbara Pieńkowska‐Grela, (unknown), (unknown), Joana Barbosa Melo, Isabel M. Carreira, Britta Meyer, Marzena Wątek, Thomas Liehr	6
16	Polyelectrolyte-mediated increase of biofilm mass formation 2015 ·BMC Microbiology ·Robert Bucki, Katarzyna Niemirowicz, Urszula Wnorowska, Marzena Wątek, Fitzroy J. Byfield, Katrina Cruz, Marta Wróblewska, Paul A. Janmey	18
17	Magnetic nanoparticles enhance the anticancer activity of cathelicidin LL-37 peptide against colon cancer cells 2015 ·International Journal of Nanomedicine ·Katarzyna Niemirowicz, (unknown), Agnieszka Z. Wilczewska, Urszula Wnorowska, Ewelina Piktel, Marzena Wątek, Paul B. Savage, Robert Bucki	63
18	Acquired hemophilia in the patient suffering from rheumatoid arthritis 2013 ·Blood Coagulation & Fibrinolysis ·(unknown), Marcin Pasiarski, Iwona Hus, (unknown), Marzena Wątek	9
19	Randomized Comparison of Cladribine Single (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients. 2006 ·Blood ·Ewa Kalinka‐Warzocha, (unknown), K Sułek, Maria Błasińska-Morawiec, (unknown), B. Ceglarek, Tadeusz Robak, Jerzy Hołowiecki, Grzegorz Mazur, (unknown), (unknown), Marzena Wątek, Krzysztof Warzocha	2
20	Randomized Multicenter Trial of Cladribine Alone (C) or in Combination with Cyclophosphamide (CC), and COP in Previously Untreated Low Grade B-Cell Non-Hodgkin Lymphoma Patients: The First Interim Analysis. 2004 ·Blood ·(unknown), (unknown), K Sułek, Tadeusz Robak, Maria Błasińska-Morawiec, Jerzy Hołowiecki, (unknown), B. Ceglarek, L Konopka, Grzegorz Mazur, (unknown), (unknown), Marzena Wątek, (unknown), J. Meder, (unknown), Ilona Seferyńska, Jarosław Czyż, Krzysztof Warzocha	2

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact